Cel-Sci Net Tangible Assets

The latest net tangible assets for CVM is $11B as of June 2026. That compares with $7M in the prior-year period — up 155855.6% year over year. Investors often review this figure alongside Cel-Sci's historical trend and sector peers before judging valuation or financial health.

Over the past year, CVM's net tangible assets moved from $7M to $11B — a 155855.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cel-Sci's operating scale or balance-sheet position.

A net tangible assets figure of $11B for CVM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CVM's net tangible assets ($11B), review year-over-year change from $7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Cel-Sci's net tangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.